Detalhe da pesquisa
1.
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens.
J Med Virol
; 91(11): 1937-1943, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31286527
2.
Determinants of patient and health care services delays for tuberculosis diagnosis in Italy: a cross-sectional observational study.
BMC Infect Dis
; 18(1): 690, 2018 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30572830
3.
Glomerular filtration rate estimated by cystatin C formulas in HIV-1 patients treated with dolutegravir, rilpivirine or cobicistat.
New Microbiol
; 41(4): 256-261, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30252923
4.
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients.
BMC Infect Dis
; 17(1): 723, 2017 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29145807
5.
A case of mild pulmonary disease due to Mycobacterium shimoidei with a favorable outcome.
J Clin Microbiol
; 51(10): 3467-8, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23926163
6.
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients.
Int J Antimicrob Agents
; 55(3): 105893, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31926287
7.
Cystic echinococcosis in the abdominal wall.
J Travel Med
; 30(6)2023 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37462529
8.
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen.
Int J Antimicrob Agents
; 52(4): 492-499, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30009958
9.
Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load.
PLoS One
; 13(2): e0191300, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29451870
10.
Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.
PLoS One
; 12(8): e0182007, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28763473
11.
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.
PLoS One
; 12(10): e0186549, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29088223
12.
An observational, retrospective analysis evaluating switching to raltegravir plus abacavir/lamivudine in HIV-1-infected patients: the ORASWIRAL study.
Infect Dis (Lond)
; 50(3): 220-222, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28891371
13.
Simplification to a dual regimen with darunavir/ritonavir plus lamivudine or emtricitabine in virologically-suppressed HIV-infected patients.
J Infect
; 73(6): 619-623, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27575581